Quince therapeutics inc QNCX.US Value Analysis
US StockHealth Care
(No presentation for QNCX)
QNCX Value Score
3
24
15
Average Growth
- AI analysis rates QNCX with a medium value score of 3.
- It is mainly due to adequate safety shown in the balance sheet, but with concerns regarding unstable operating cash flow.
- Over the past 3 months, QNCX has maintained a consecutive value rating of 3.0, slightly higher than the rating of 1.9 over the past 3 years, indicating higher growth opportunities for enterprise value.
- Compared to all stocks in the Health Care sector, QNCX has a medium value rating.
QNCX Value Reference Factors
The Value score is derived from various data and factor information, integrated through AI algorithms. The following factors are part of the evaluation used by AI value scores.
No related data records
Update to 2025/03/27 (Weekly Update)
QNCX Financial Forecast
Unit : USD
Update to 2025/5/17 (Quarterly Update)
QNCX Earnings Table
No related data records
QNCX Historical Value Score
You can use historical scores of 3 or above to observe potential performance and make investment decisions.
QNCX Value Strategy Backtest
The following backtest is based on specified rules since 2007. Price chart shows buy/sell time, cumulative returns, and backtesting statistics.
Entry
Exit
The Backtest Result of QNCX from 2019/05 till Now
- -
- Cumulative Return
- -
- Annual Return
- -
- Volatility
- -
- Sharpe Ratio
Statistics data for entering at or above a Value score of 4 and exiting at or below a Value score of 2 from May, 2019 to May, 2025. (Total Trades: 0)
| QNCX | Sector | US Overall Market | |
|---|---|---|---|
| Wining Rate | - | 45% | 54% |
| Avg Return | - | 63.7% | 75.6% |
| Avg Profit | - | 197.8% | 169% |
| Avg Loss | - | -44.7% | -34.6% |
| Avg Risk-Reward Ratio | - | 442.4% | 488.5% |
Update to 2025/5/17 (Daily Update)